Have You or a Loved One Been Injured?

Contact us for a free case evaluation.
Personal Injury Blog
Practice Areas
Personal Injury
Auto Accidents
BP Oil Spill Claims
Commercial Litigation
Construction Accidents
Employment Law
Environmental Litigation
Medical Malpractice
Mesothelioma
Pharmaceutical Litigation
Product Liability
Sandy Insurance Claims
Securities Arbitration
Social Security Disability
Union Workers
Workers' Compensation
Wrongful Death
WTC / Zadroga Act

Contact Us

Send an email to our office.

I have read the disclaimer.
Yes, sign up for newsletter.

Recent Posts in FDA Prescription Drugs Category

What is fungal meningitis?

Just a month ago, the focus on fungal meningitis, a rare but potentially deadly infection, was virtually nonexistent. Today it is receiving attention across the United States after an outbreak that ...
Continue reading "What is fungal meningitis?" »

14,000 Patients May Have Received Injections from Affected Lots of Steroid Injections Linked to Meningitis Outbreak

According to estimates from the Centers for Disease Control and Prevention (CDC) and state health departments, approximately 14,000 patients may have received injections from the three contaminated ...
Continue reading "14,000 Patients May Have Received Injections from Affected Lots of Steroid Injections Linked to Meningitis Outbreak" »

Meningitis Outbreak Claims 25 Lives, According to Latest CDC Update

With a 10th death reported in Tennessee, the death toll related to the fungal meningitis outbreak has reached 25. The latest report from the Centers for Disease Control and Prevention (CDC) is that ...
Continue reading "Meningitis Outbreak Claims 25 Lives, According to Latest CDC Update" »

FDA Confirms Contamination in Pharmacy Linked to Fungal Meningitis Outbreak

In a report released on October 26, the Food and Drug Administration (FDA) discussed conditions investigators observed at the New England Compounding Center (NECC), the pharmacy that has been linked ...
Continue reading "FDA Confirms Contamination in Pharmacy Linked to Fungal Meningitis Outbreak" »

How are new drugs approved by the FDA?

When a drug company wishes to sell a prescription drug in the United States, it must first get approval from the U.S. Food and Drug Administration (FDA). The FDA works to protect and promote public ...
Continue reading "How are new drugs approved by the FDA?" »

Latest CDC report on meningitis outbreak: 328 cases in 18 states

According to the latest update from the U.S. Centers for Disease Control and Prevention (CDC) as of today, October 25, 2012, the current case count in the multistate fungal meningitis outbreak has ...
Continue reading "Latest CDC report on meningitis outbreak: 328 cases in 18 states" »

FDA releases 73-page list of New England Compounding Center customers

Just two days ago, the Food and Drug Administration (FDA) released a list of facilities that had received products from the New England Compounding Center (NECC) that were shipped on or after May 21, ...
Continue reading "FDA releases 73-page list of New England Compounding Center customers" »

FDA requests recall of Budeprion XL, generic equivalent of Wellbutrin

Though originally approved by the Food and Drug Administration (FDA) in December of 2006, Budeprion XL 300 mg is now being recalled. The generic equivalent of Wellbutrin XL 300 mg, Budeprion was ...
Continue reading "FDA requests recall of Budeprion XL, generic equivalent of Wellbutrin" »

FDA faces lawsuit regarding Alzheimer's drug

The Food and Drug Administration (FDA) is known as a regulator of the pharmaceutical industry, working to protect the public by ensuring the safety and effectiveness of prescription and ...
Continue reading "FDA faces lawsuit regarding Alzheimer's drug" »

FDA approves generic version of Actos

Pioglitazone, previously only marketed as Actos by Takeda Pharmaceuticals, has now been approved by the Food and Drug Administration (FDA). This generic version of the antidiabetic drug is chemically ...
Continue reading "FDA approves generic version of Actos" »

FDA approves second weight loss drug in two months

For over a decade, obese Americans have had limited options when it comes to FDA-approved weight loss medications that are seen as relatively safe. This trend may be linked to the rise and fall of ...
Continue reading "FDA approves second weight loss drug in two months" »

Auxilium Pharmaceuticals shares fall 3 percent after releasing data on Xiaflex study

Auxilium Pharmacueticals Inc manufactures Xiaflex, a drug approved in early 2010 by the Food and Drug Administration (FDA) for the treatment of Dupuytren's contracture, a medical condition ...
Continue reading "Auxilium Pharmaceuticals shares fall 3 percent after releasing data on Xiaflex study" »

People on common blood pressure drug may be misdiagnosed, unnecessarily treated for celiac disease

A new study has found that use of a commonly prescribed high blood pressure medication is associated with severe gastrointestinal symptoms that mimic celiac disease, possibly leading to misdiagnosis ...
Continue reading "People on common blood pressure drug may be misdiagnosed, unnecessarily treated for celiac disease" »

FDA warns of overdose risk from overfilled Hospira Carpuject® syringe cartridges

The Food and Drug Administration (FDA) has issued a warning related to Hospira drug products, which may contain incorrect drug dosages as the result of a manufacturing error at the facility. Hospira, ...
Continue reading "FDA warns of overdose risk from overfilled Hospira Carpuject® syringe cartridges" »

Transdermal patch and vaginal ring contraceptives present higher risk of blood clots, according to a new study

A new study has revealed that vaginal ring and transdermal patch contraceptives may present a higher risk of clotting in women who use these forms of birth control as opposed to certain oral ...
Continue reading "Transdermal patch and vaginal ring contraceptives present higher risk of blood clots, according to a new study" »

New study shows injectable contraceptive Depo-Provera® may double risk of breast cancer

A new study has linked Depo-Provera®, an injectable contraceptive, with an increased risk of breast cancer. The study, conducted by researchers at the Fred Hutchinson Cancer Research Center, ...
Continue reading "New study shows injectable contraceptive Depo-Provera® may double risk of breast cancer" »

Plant mix-up leads to recall of Excedrin, Gas-X, Bufferin and NoDoz

Novartis Consumer Health, Inc. has issued a warning and recall after an issue at a production facility may have caused commingling of prescription and over-the-counter medications. Novartis has ...
Continue reading "Plant mix-up leads to recall of Excedrin, Gas-X, Bufferin and NoDoz" »
Client Testimonials Attorneys in the News Case Evaluation
Napoli Bern Ripka Shkolnik LLP
New York Personal Injury Lawyer
Located at 350 5th Avenue, Suite 7413,
New York, NY 10118.
Phone: (212) 267-3700.
Website: .
Napoli Bern Ripka Shkolnik, LLP
Personal Injury Lawyers
© 2012 All Rights Reserved. | Privacy Policy